Core Viewpoint - The company has decided to terminate the development of prothrombin complex concentrate and shift focus to the more advantageous development of human coagulation factor IX, due to market demand, competitive landscape, and cost-effectiveness considerations [1][2]. Market Demand and Competitive Landscape - The domestic market for prothrombin complex concentrate has seen stable issuance volumes with limited new market space, while the market for human factor IX has fewer competitors and significant growth potential [1]. - Human factor IX is considered a better option for treating hemophilia B due to its lower risk of thrombotic side effects compared to prothrombin complex concentrate [1][2]. Product Comparison Analysis - Prothrombin complex concentrate contains various vitamin K-dependent factors and may pose risks of thrombosis with repeated high-dose use, while human factor IX is purer and has a higher specific activity, making it a safer treatment option [1][2]. Cost-Effectiveness Analysis - The clinical trial approval for prothrombin complex concentrate was obtained in 2008, but the regulatory requirements for production site changes and the need for extensive research have made it less economically viable compared to human factor IX, which has a higher sales price and greater market growth potential [2][4]. Project Background and Investment Plan - The genomic DNA length of human factor IX is approximately 34,000 bp, and the project is expected to complete development and obtain production approval by the end of 2030 [2][4]. - The estimated investment for the development of human factor IX is 60 million yuan, with funding sourced from both raised capital and the company's own funds [4]. Project Benefits and Feasibility - The human factor IX product is aimed at treating patients with factor IX deficiency (hemophilia B), and the limited number of competitors in this market suggests significant future growth opportunities [5]. - The project aligns with market trends and the company's operational needs, enhancing resource allocation and economic benefits, thereby improving profitability and market competitiveness [5][7]. Implementation Timeline - The implementation timeline for the new product development is expected to be completed by the end of 2030, with the associated production line construction already finished [6][4]. Impact of Changes on the Company - The termination of the prothrombin complex concentrate project will reduce the current year's net profit but is expected to enhance the company's future product development and sales capabilities [7]. - The board and supervisory committee have approved the change in fundraising purposes, emphasizing the alignment with the company's operational needs and long-term interests [8][10].

Core Viewpoint - The company has announced a change in the use of raised funds, shifting from overseas projects to domestic mining projects, aiming to optimize fund allocation efficiency and focus on high-quality domestic mining markets [1][2]. Fund Usage Change - The company plans to redirect approximately 1.18 billion yuan of the originally raised 1.2 billion yuan for the "Mining Engineering Construction and Mining Equipment Purchase Project" to the "Anning Mining Panketian Iron Mine Open-pit to Underground Mining Project" [1]. - The original project intended to use funds for equipment procurement in overseas mining projects in countries like the Democratic Republic of Congo and Zambia, but only 185.48 million yuan of the raised funds were utilized, with 72.4% of the total investment completed through self-funding [1][2]. Project Details - The "Anning Mining Panketian Iron Mine Open-pit to Underground Mining Project" has a contract value of 3.8 billion yuan (excluding tax) and a construction period of 1500 calendar days, signed with Anning Mining Co., Ltd. on April 1, 2025 [3]. - The project includes critical mining facilities such as three vertical shafts and a mineral recovery system, with construction having commenced on April 20, 2025 [3]. Financial Performance - As of the end of June, the company reported total revenue of approximately 710 million yuan, reflecting a year-on-year increase of 8.35%, and a net profit attributable to shareholders of approximately 44.71 million yuan, up 3.72% year-on-year [3].

Core Viewpoint - The company announced a change in the use of part of the raised funds, reallocating 50 million yuan from the original project to a new project, which is expected to enhance the efficiency of fund utilization [1] Fund Allocation Changes - The company plans to change the use of 50 million yuan of the raised funds, which represents 3.37% of the net amount raised [1] - The funds were originally intended for the "East China Testing Base Project" and will now be redirected to the "Central China (Wuhan) Testing Base Project" [1] - This change does not involve any new investment projects and does not constitute a related party transaction [1] Governance - The proposal for changing the fund usage will be submitted for approval at the upcoming shareholders' meeting [1]

Core Points - The company did not distribute cash dividends or issue bonus shares during the reporting period [3] - The company has not experienced any changes in its controlling shareholder or actual controller during the reporting period [5] - The company has made changes to some fundraising investment projects, reallocating 100.409 million yuan from the "Ningxia Quartz Crucible Phase II Project" to a new project, "Semiconductor Quartz Crucible Construction Project" [7] Financial Data - As of June 30, 2025, the remaining convertible bonds "Oujing Convertible Bonds" amounted to 4,693,063 units, with a total face value of 469.306 million yuan [5][6] - During the reporting period, 1,748 units of "Oujing Convertible Bonds" were converted, resulting in an increase of 4,155 shares [5] Important Matters - The company activated the additional repurchase clause for "Oujing Convertible Bonds" due to changes in some fundraising projects, allowing bondholders to exercise a one-time repurchase right [6] - The effective repurchase application quantity during the repurchase period was 30 units [6]

Core Viewpoint - The company is adjusting its fundraising project due to lower-than-expected market demand for its smart cold chain and vending machine products, leading to a change in investment allocation towards a new project in Indonesia [1][4]. Group 1: Project Overview - The total planned investment for the "Smart Cold Chain Equipment and Commercial Vending Machine Industrialization Project" is 652.42 million yuan, with major allocations for site investment (48.41%), equipment purchase and installation (41.15%), working capital (5.96%), and basic reserve funds (4.48%) [1]. - As of June 30, 2025, the project has utilized approximately 264.36 million yuan of the raised funds, with a remaining balance of about 269.54 million yuan [2]. Group 2: Project Progress and Adjustments - The project has not yet reached the expected operational status, with a revised completion date set for December 31, 2025. Land acquisition is complete, and some construction has been finished [2]. - The original project planned to add 32,500 smart cold chain vending machines and 47,500 commercial vending machines, but the slow penetration of the unmanned retail industry and a decline in the fast-moving consumer goods sector have led to a slowdown in project progress [3]. Group 3: Financial Adjustments - As of June 30, 2025, the actual site investment was 185.93 million yuan, which is 129.90 million yuan less than originally planned, and equipment purchase and installation costs were 78.42 million yuan, falling short by 190.08 million yuan [4]. - The company plans to adjust the project scale downwards, resulting in a lower required investment amount. The surplus funds will be redirected to a new project in Indonesia, which requires additional investment due to increased building area and production capacity [4].

Core Viewpoint - Qingdao Hairong Commercial Cold Chain Co., Ltd. announced a change in the use of part of the raised funds for its project due to lower-than-expected market demand and adjustments in project planning [1][2][3][4]. Fund Utilization and Project Details - The "Intelligent Cold Chain Equipment and Commercial Vending Machine Industrialization Project" has a total planned investment of 652.42 million yuan, with 493.74 million yuan intended to be funded by raised capital [1]. - As of June 30, 2025, the project has utilized approximately 264.36 million yuan of the raised funds, leaving a balance of about 269.54 million yuan [2]. - The project has faced delays, with an expected completion date now set for December 31, 2025, due to slower-than-anticipated market penetration in the unmanned retail sector and a decline in the growth rate of the fast-moving consumer goods industry [2][3]. Adjustments in Project Planning - The actual investment in land and equipment has fallen short of the original plan, with land investment at 185.93 million yuan, which is 129.90 million yuan less than planned, and equipment costs at 78.42 million yuan, which is 190.08 million yuan less than planned [3]. - The company has determined that existing production capacity is sufficient to support future domestic business needs, leading to no plans for further large-scale investments in the original project [3]. Reallocation of Funds - The company plans to reallocate over 90 million yuan of the remaining raised funds to a new project in Indonesia, which involves establishing a subsidiary and building a commercial display cabinet manufacturing plant [4]. - This reallocation is necessary due to increased construction area, adjustments in production line layout, and the need for additional production equipment to enhance the production capacity of intelligent vending machines and commercial vending machines [4].

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內 容 概 不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不對因本公告全部或任何部分內容而產生或因倚賴該等內容而引致的 任 何 損 失 承 擔 任 何 責 任。 建議變更H股募集資金用途 H股募集資金基本情況 茲提述(i)本公司日期為2015年7月28日 的H股 招 股 說 明 書（「招股書」）, (ii) 本公司日期為2020年3月25日的建議變更H股 募 集 資 金 用 途 公 告（「該公告」） 及(iii)本公司日期為2020年5月15日的本公司2019年 度 股 東 週 年 大 會 通 函， 內 容 有 關（其 中 包 括）本 公 司H股募集資金基本情況及變更H股募集資金 用 途。除 另 有 界 定 者 外，本 公 告 所 用 詞 彙 與 招 股 書 及 該 公 告 所 界 定 者 具 有 相 同 涵 義。 中 國 鐵 路 通 信 信 號 股 份 有 限 公 司 China Railway Signal & Communication Corporation Limited* （在中華人 ...

Core Viewpoint - The company has approved several resolutions during its board meetings, including changes in the use of raised funds and the establishment of a wholly-owned subsidiary in Shenzhen for a research and design center, aimed at enhancing its core competitiveness and optimizing fund utilization [10][33][49]. Group 1: Company Overview - The company is named Hunan Hualian Ceramics Co., Ltd. and is publicly listed with the stock code 001216 [1]. - The company has not experienced any changes in its controlling shareholder or actual controller during the reporting period [5][6]. Group 2: Financial and Operational Decisions - The board approved a resolution to change the use of part of the raised funds amounting to 71.48 million yuan (including interest) from the engineering technology center project to the Shenzhen research and design center project [10][24]. - The total investment for the Shenzhen research and design center project is 130 million yuan, with the company planning to use up to 100 million yuan for purchasing office space [11][26]. Group 3: Related Party Transactions - The company has approved a new annual related party transaction with Hunan Yaran Porcelain Trading Co., Ltd., with an estimated total amount not exceeding 130,000 yuan for 2025 [53][54]. - The related party transactions are conducted based on fair market pricing and do not harm the company's interests [9][63]. Group 4: Upcoming Events - The company plans to hold its fourth extraordinary general meeting of shareholders on September 11, 2025, to discuss various proposals, including the changes in the use of raised funds [66][67].

Summary of Key Points Core Viewpoint The company, Hunan Hualian Ceramics Co., Ltd., is undergoing changes in the use of part of its raised funds for investment projects, aiming to enhance its strategic development and improve the efficiency of fund utilization. Group 1: Fundraising and Project Changes - The company raised a total of RMB 589,997,979.00 from the public offering of 62,966,700 shares, with a net amount of RMB 532,679,111.08 after deducting related expenses [1][2] - The company has made multiple adjustments to its fundraising projects, including changes approved in various shareholder meetings, focusing on optimizing the use of funds for specific projects [3][4] Group 2: New Project Details - The company plans to allocate RMB 71,483,700 (including interest) from the engineering technology center project to the Shenzhen R&D Design Center project [5][6] - The total investment for the Shenzhen R&D Design Center project is RMB 130,000,000, with RMB 71,483,700 proposed to be funded from the raised funds [7][8] Group 3: Strategic Reasons for Changes - The changes are aligned with the company's strategic development needs, aiming to enhance core competitiveness and attract high-level talent by establishing the R&D center in Shenzhen [6][9] - The company emphasizes the importance of optimizing fund allocation to improve the efficiency of fund usage and adapt to market trends [6][10] Group 4: Decision-Making Process - The changes in the use of funds have been reviewed and approved by the company's board of directors, supervisory board, and independent directors, ensuring compliance with relevant laws and regulations [12][13] - The independent directors confirmed that the adjustments are necessary for the company's operational needs and do not harm the interests of shareholders [12][13]

Summary of Key Points Core Viewpoint The report outlines the fundraising activities and the usage of proceeds from the convertible bonds issued by Hangzhou Tiandi Digital Technology Co., Ltd. It highlights the total amount raised, the allocation of funds, and the changes in project funding due to strategic adjustments. Group 1: Fundraising Overview - The company raised a total of RMB 172 million through the issuance of 1,720,000 convertible bonds at a face value of RMB 100 each, with net proceeds amounting to RMB 166.4 million after deducting fees [1][2] - As of June 30, 2025, the net amount of raised funds was RMB 164.297 million, with RMB 6.69963 million utilized for various projects [2][3] Group 2: Fund Usage and Management - The company has allocated RMB 9.47507 million of the unutilized funds and its interest income to a new project, the "Annual Production Line of 230 Million Square Meters of Intelligent Recognition Materials (Phase II)" [3][4] - The company signed tripartite supervision agreements with banks to ensure proper management of the raised funds [2][3] Group 3: Changes in Fund Allocation - The company decided to change the use of the raised funds from the original projects, including "Heat Transfer Coating Equipment and Product Technology Upgrade Project," to the new project due to market conditions affecting the original plans [4][5] - The total investment for the new project is RMB 100.1834 million, with the company providing the funds through loans, while the remaining amount will be covered by the subsidiary's own funds [3][4] Group 4: Financial Management of Idle Funds - The company is authorized to use up to RMB 80 million of idle funds for cash management, investing in safe and liquid financial products [5][10] - As of June 30, 2025, the company had no idle funds temporarily supplementing working capital [5][10] Group 5: Fund Balance and Future Plans - As of June 30, 2025, the remaining balance of the raised funds was RMB 62.669 million, which will be gradually invested in the committed projects [11] - The company has not encountered any issues regarding the use and disclosure of the raised funds, ensuring compliance with relevant regulations [7][8]